← Leaderboards
Daliao Xiao
Loma Linda University
$4,636,062
Attributed
$7,407,180
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,407,180 · 5
By mechanism
R01$3,883,969 · 2
U01$3,290,961 · 1
R03$232,250 · 2
Top collaborators
- Xuesi Max Shao5 shared
- Charles Wang3 shared
Others in their field
Top investigators on “Rattus”
- Barney Sparrow · Battelle Memorial Institute$76,162,078
- Reshan Fernando · Research Triangle Institute$42,714,061
- Boris Tabakoff · University Of Colorado Denver$35,561,072
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$35,063,410
- Milton D Hejtmancik · Battelle Centers/Pub Hlth Res & Evaluatn$34,625,987
- John Damon Chodera · Sloan-Kettering Inst Can Research$33,543,727
Research focus
RattusMolecularNicotineOffspringPublic HealthFetalFetal ProgrammingLifePregnancyEpigenetic ProcessWomanPhenotypeCardiovascular SystemMediatingAdultGene ExpressionPregnantBlood VesselsAdult ChildrenCardiovascular DiseasesCardiovascular Disorder RiskChildGenesMaternal Cigarette Smoking
Grant awards (17)
Genomic and Epigenomic Mechanisms of Maternal E-Cigarette induced Abnormal Brain Development$1,223,346
U01 · FY2025 · DA
Genomic and Epigenomic Mechanisms of Maternal E-Cigarette induced Abnormal Brain Development$1,070,336
U01 · FY2024 · DA
Genomic and Epigenomic Mechanisms of Maternal E-Cigarette induced Abnormal Brain Development$997,279
U01 · FY2023 · DA
Maternal inhaled nicotine leads to aberrant development of hypertensive phenotype$430,503
R01 · FY2021 · HL · contact PI
miRNA as a novel therapeutic target in antenatal nicotine-induced ischemic heart$321,293
R01 · FY2021 · HD · contact PI
Maternal inhaled nicotine leads to aberrant development of hypertensive phenotype$440,741
R01 · FY2020 · HL · contact PI
miRNA as a novel therapeutic target in antenatal nicotine-induced ischemic heart$327,850
R01 · FY2020 · HD · contact PI
Maternal inhaled nicotine leads to aberrant development of hypertensive phenotype$447,061
R01 · FY2019 · HL · contact PI
miRNA as a novel therapeutic target in antenatal nicotine-induced ischemic heart$327,850
R01 · FY2019 · HD · contact PI
Maternal inhaled nicotine leads to aberrant development of hypertensive phenotype$456,811
R01 · FY2018 · HL · contact PI
miRNA as a novel therapeutic target in antenatal nicotine-induced ischemic heart$327,850
R01 · FY2018 · HD · contact PI
Nicotine-mediated fetal programming of vascular dysfunction phenotype$79,000
R03 · FY2018 · DA · contact PI
Maternal inhaled nicotine leads to aberrant development of hypertensive phenotype$476,160
R01 · FY2017 · HL · contact PI
miRNA as a novel therapeutic target in antenatal nicotine-induced ischemic heart$327,850
R01 · FY2017 · HD · contact PI
Nicotine-mediated fetal programming of vascular dysfunction phenotype$79,000
R03 · FY2017 · DA · contact PI
Fetal Programming of Vascular Dysfunction by Nicotine Exposure$37,125
R03 · FY2012 · DA · contact PI
Fetal Programming of Vascular Dysfunction by Nicotine Exposure$37,125
R03 · FY2011 · DA · contact PI